Down-regulation of hepatic lipase expression by elevation of cAMP in human hepatoma but not adrenocortical cells

D Deursen, GJ (Gerrit Jan) Botma, H Jansen, Adrie Verhoeven

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)

Abstract

Expression of hepatic lipase (HL) in the liver is reduced during prolonged fasting. This effect is mainly mediated via catecholamines, which signal through elevation of Ca-i(2+) as well as cAMP. We have studied the effect of cAMP on HL expression in cell culture. Overnight incubation of HepG2 cells with 10-300 mu M 8-bromo-cyclic AMP resulted in a dose-dependent, up to 50% reduction in secretion of HL, but had no effect on secretion of alpha 1-antitrypsin or overall protein synthesis. HL mRNA levels were decreased 1.5 fold, as determined by semi-quantitative and real-time RT-PCR. In HepG2 cells transiently transfected with human HL (-685/+13) or rat HL (-446/+9) promoter-reporter constructs, cAMP induced a similar dose-dependent suppression of HL promoter activity. cAMP responsiveness in HepG2 cells was mediated by a conserved 10-bp response element at -45/-36, that represents a potential binding site for CCAAT/enhancer-binding protein beta (C/EBP beta). cAMP reduced expression of the 45 kDa C/EBP beta protein and binding of C/EBP beta to the proximal promoter region of the human HL gene by 50%, as determined by immunoblotting and chromatin immunoprecipitation assay, respectively. In human H295R adrenocorticall cells, cAMP failed to suppress HL promoter activity, and only slightly reduced C/EBP beta expression. We conclude that the fall in HL expression during prolonged fasting may be mediated through elevation of cAMP and lowering of C/EBP beta expression. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)37-44
Number of pages8
JournalMolecular and Cellular Endocrinology
Volume294
Issue number1-2
DOIs
Publication statusPublished - 2008

Research programs

  • EMC COEUR-01-43-01

Cite this